Literature DB >> 10355609

Effect of 4-methylthiobenzoic acid on cisplatin-induced ototoxicity in the rat.

T Kamimura1, C A Whitworth, L P Rybak.   

Abstract

The purpose of this study was to investigate the effectiveness of 4-methylthiobenzoic acid (MTBA) as a protection agent against cisplatin (CDDP)-induced changes in organ of Corti surface structure, compared to electrophysiological changes. Electrophysiological change was assessed using auditory brainstem response (ABR) and morphological changes were assessed using scanning electron microscopy (SEM). Male Wistar rats underwent pre-treatment ABRs in response to clicks, and tone bursts at 2, 4, 8, 16, and 32 kHz. The three groups of rats were injected as follows: (1) MTBA (250 mg/kg, i.p.), (2) CDDP (16 mg/kg, i.p.), (3) CDDP+MTBA (16 mg/kg, i.p. + 250 mg/kg, i.p.). Post-treatment ABRs were performed 3 days after drug administration and rats were sacrificed. Their cochleae were harvested and SEM was used to examine the surface of the organ of Corti, specifically the number of inner hair cells (IHCs) and outer hair cells (OHCs) in the apical, middle and basal turns of the cochlea. Animal weight was measured on the first and final days. There was a good correlation between ABR threshold changes and hair cell loss in the high frequency region of the cochlea (basal turn), while threshold changes in the lower test frequencies (middle turn) appeared to be the result of more subtle changes in the cochlea. MTBA provided effective protection against cisplatin-induced ABR threshold changes at all test frequencies as well as hair cell loss. MTBA also protected against body weight loss.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10355609     DOI: 10.1016/s0378-5955(99)00017-9

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  15 in total

1.  Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?

Authors:  Issam Saliba; Fouad El Fata
Journal:  Neurotox Res       Date:  2011-10-12       Impact factor: 3.911

Review 2.  Effect of intratympanic dimethyl sulphoxide (DMSO) in an in vivo model of cisplatin-related ototoxicity.

Authors:  A Roldán-Fidalgo; A Trinidad; A Rodríguez-Valiente; J R García-Berrocal; I Millán; M J Coronado; R Ramírez-Camacho
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-08       Impact factor: 2.503

3.  Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Tejbeer Kaur; Kelly E Sheehan; Vickram Ramkumar; Leonard P Rybak
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

Review 4.  Recent advances in the development and function of type II spiral ganglion neurons in the mammalian inner ear.

Authors:  Kaidi D Zhang; Thomas M Coate
Journal:  Semin Cell Dev Biol       Date:  2016-10-17       Impact factor: 7.727

5.  NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Kelly Sheehan; Tejbeer Kaur; Sandeep Sheth; Jennifer Bunch; Christopher Perro; Leonard P Rybak; Vickram Ramkumar
Journal:  Antioxid Redox Signal       Date:  2010-12-07       Impact factor: 8.401

6.  The protective effect of aspirin-induced temporary threshold shift in an animal model of cisplatin-related ototoxicity.

Authors:  Sharon Tzelnick; Aviram Mizrachi; Neta Barkan; Shaked Shivatzki; Eyal Yosefof; Elad Hikri; Joseph Attias; Ohad Hilly
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-01       Impact factor: 4.553

7.  Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures.

Authors:  Weidong Qi; Dalian Ding; Richard J Salvi
Journal:  Hear Res       Date:  2007-12-15       Impact factor: 3.208

8.  Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Craig Whitworth; Jennifer R Bunch; Jeremy G Turner; Leonard P Rybak; Vickram Ramkumar
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

Review 9.  siRNA-mediated knock-down of NOX3: therapy for hearing loss?

Authors:  Leonard P Rybak; Debashree Mukherjea; Sarvesh Jajoo; Tejbeer Kaur; Vickram Ramkumar
Journal:  Cell Mol Life Sci       Date:  2012-05-05       Impact factor: 9.261

10.  Different uptake of gentamicin through TRPV1 and TRPV4 channels determines cochlear hair cell vulnerability.

Authors:  Jeong-Han Lee; Channy Park; Se-Jin Kim; Hyung-Jin Kim; Gi-Su Oh; AiHua Shen; Hong-Seob So; Raekil Park
Journal:  Exp Mol Med       Date:  2013-03-08       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.